201 related articles for article (PubMed ID: 36165032)
1. Inhibition of
Węglińska L; Bekier A; Trotsko N; Kaproń B; Plech T; Dzitko K; Paneth A
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2621-2634. PubMed ID: 36165032
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo susceptibility to sulfadiazine and pyrimethamine of Toxoplasma gondii strains isolated from Brazilian free wild birds.
de Lima Bessa G; Vitor RWA; Lobo LMS; Rêgo WMF; de Souza GCA; Lopes REN; Costa JGL; Martins-Duarte ES
Sci Rep; 2023 May; 13(1):7359. PubMed ID: 37147353
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
5. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Romand S; Pudney M; Derouin F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
[TBL] [Abstract][Full Text] [Related]
7. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.
Mack DG; McLeod R
Antimicrob Agents Chemother; 1984 Jul; 26(1):26-30. PubMed ID: 6383209
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and In Vitro Anti-
Trotsko N; Bekier A; Paneth A; Wujec M; Dzitko K
Molecules; 2019 Aug; 24(17):. PubMed ID: 31438527
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.
Wang JL; Elsheikha HM; Li TT; He JJ; Bai MJ; Liang QL; Zhu XQ; Cong W
Int J Antimicrob Agents; 2019 Dec; 54(6):814-819. PubMed ID: 31479744
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.
Meneceur P; Bouldouyre MA; Aubert D; Villena I; Menotti J; Sauvage V; Garin JF; Derouin F
Antimicrob Agents Chemother; 2008 Apr; 52(4):1269-77. PubMed ID: 18212105
[TBL] [Abstract][Full Text] [Related]
11. Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil.
Silva LA; Reis-Cunha JL; Bartholomeu DC; Vítor RW
PLoS One; 2017; 12(1):e0170689. PubMed ID: 28118394
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Potent and Selective Halogen-Substituted Imidazole-Thiosemicarbazides for Inhibition of
Paneth A; Węglińska L; Bekier A; Stefaniszyn E; Wujec M; Trotsko N; Hawrył A; Hawrył M; Dzitko K
Molecules; 2019 Apr; 24(8):. PubMed ID: 31022878
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of sulfadiazine and its metabolites alone and in combination with pyrimethamine on Toxoplasma gondii.
Schoondermark-van de Ven E; Vree T; Melchers W; Camps W; Galama J
Antimicrob Agents Chemother; 1995 Mar; 39(3):763-5. PubMed ID: 7793889
[TBL] [Abstract][Full Text] [Related]
14. Sulfadiazine analogs: anti-Toxoplasma in vitro study of sulfonamide triazoles.
Arafa FM; Osman DH; Tolba MM; Rezki N; Aouad MR; Hagar M; Osman M; Said H
Parasitol Res; 2023 Oct; 122(10):2353-2365. PubMed ID: 37610452
[TBL] [Abstract][Full Text] [Related]
15. Anti-toxoplasma activities of antiretroviral drugs and interactions with pyrimethamine and sulfadiazine in vitro.
Derouin F; Santillana-Hayat M
Antimicrob Agents Chemother; 2000 Sep; 44(9):2575-7. PubMed ID: 10952623
[TBL] [Abstract][Full Text] [Related]
16. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
[TBL] [Abstract][Full Text] [Related]
17. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
[TBL] [Abstract][Full Text] [Related]
18. A new iron(III) complex-containing sulfadiazine inhibits the proliferation and induces cystogenesis of Toxoplasma gondii.
Portes JA; Azeredo NFB; Siqueira PGT; de Souza TG; Fernandes C; Horn A; Candela DRS; de Souza W; DaMatta RA; Seabra SH
Parasitol Res; 2018 Sep; 117(9):2795-2805. PubMed ID: 29934691
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anti-parasitic activities of new quinolones containing nitrofuran moiety against Toxoplasma gondii.
Sadeghi M; Sarvi S; Emami S; Khalilian A; Hosseini SA; Montazeri M; Shahdin S; Nayeri T; Daryani A
Exp Parasitol; 2022 Sep; 240():108344. PubMed ID: 35931176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]